Facing Time in Ischemic Stroke: An Alternative Hypothesis for Collateral Failure by M. Pham & M. Bendszus
R E V I E W A RT I C L E
Received: 30 December 2015 / Accepted: 11 February 2016 / Published online: 7 March 2016
© The Author(s) 2016. This article is published with open access at Springerlink.com
Facing Time in Ischemic Stroke: An Alternative Hypothesis for 
Collateral Failure
M. Pham1 · M. Bendszus1
Clin Neuroradiol (2016) 26:141–151
DOI 10.1007/s00062-016-0507-2
Introduction
With the advance of highly effective endovascular treat-
ment strategies [1–5] one further step in stroke treatment 
is to bring more patients within the reach of therapeutic 
recanalization. Hence, the future goal to further improve 
acute stroke therapy will have to be moved beyond the seg-
ment of arterial occlusion by aiming at the sustenance of 
the ischemic tissue-at-risk downstream (i.e., the penumbra) 
until recanalization can be achieved. This is highly desirable 
because with such a strategy at hand, additional time could 
be “bought” for the large number of patients in whom recan-
alization cannot be achieved fast enough by whatever type 
of intervention. In this regard, it is certainly among the most 
prominently discussed targets to increase the compensatory 
capacity of the pial (syn. leptomeningeal) collateral macro-
vasculature for maintaining sufficient blood flow into the 
ischemic penumbra [6]. Based on clinical key observations 
of collateral flow in acute ischemic stroke [3, 7], the pursuit 
of a therapeutic strategy which enhances macrovascular pial 
collateral blood flow seems reasonable and logical.
These key observations can be summarized as follows:
1. Poor macrovascular pial collateral filling, as docu-
mented by computed tomography- (CT-), magnetic 
resonance- (MR-), or invasive digital subtraction an-
giography at baseline (before recanalization), is linked 
to poor outcome even if the occluded vessel segment is 
completely recanalized (a representative example of this 
observation is given in the upper row of Fig. 1).
2. Strong macrovascular pial collateral filling, as docu-
mented before recanalization, is linked to favorable out-
come particularly if the occluded vessel segment can be 
recanalized successfully (a representative example of 
this observation is given in the middle row of Fig. 1).
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effects so disastrous. There are instances, rare it is true, in 
which obstruction involving either a branch of the Sylvian 
artery [i.e. the middle-cerebral-artery] or the trunk of this 
vessel, in which such an occurrence may even remain with-
out appreciable result.” [8].
Taking into consideration all these observations, the fail-
ure of macrovascular pial collaterals has been held respon-
sible as a major cause of progressive cerebral infarction by 
many clinical and experimental researchers [9, 10]. This 
view strongly promotes that it seems particularly promising 
to enhance the structure and/or function of the pial collateral 
macrovasculature as a future therapeutic target.
In 2003, a very comprehensive review of this topic 
demonstrated, by reaching as far back as Heubner’s first 
observation of the macrovascular pial collaterals in 1872, 
that there has been an astonishingly regular periodicity of 
opposing trends and opinions either supporting or negat-
ing the view that the failure of the compensatory capac-
ity of pial collaterals causes progressive infarction of the 
penumbra [9]. In the 1980s and 1990s of the past century, 
considerable reluctance prevailed to accept the failure of 
pial collaterals as a dominant factor in the progression of 
cerebral infarction [11–13]. Subsequently, another period 
arrived with its possible peak being in 2015 and 2016 when 
several randomized controlled trials (RCTs) proved strong 
treatment effects of endovascular recanalization in ischemic 
stroke caused by large vessel occlusion (e.g., of the M1 seg-
ment) [1–5]. Among these studies, particularly the findings 
of the ESCAPE study are highly relevant for research on the 
pial collateral macrovasculature [3].
In the The Endovascular Treatment for Small Core and 
Anterior Circulation Proximal Occlusion with Emphasis on 
Minimizing CT to Recanalization Times (ESCAPE) study, 
multiphase CT angiography was elegantly utilized to visu-
alize with high structural resolution how the macrovascular 
pial arterial tree within the ischemic MCA field is filled by 
collateral backflow [3]. In this manner, the ESCAPE study 
arguably produced the best available data so far corrobo-
rating the strong association between robust collateraliza-
tion and favorable outcome after recanalization. However, 
the cause–effect relationship between macrovascular pial 
collateral flow and outcome after recanalization may not 
be satisfactorily explained by the simple assumption that 
insufficient or declining pial collateral flow causes rapidly 
progressive infarction of the penumbra.
Collateral failure: just a secondary consequence of 
progressive infarction?
This review summarizes clinical and experimental evi-
dence which allows the alternative view that the cessation 
of blood flow through macrovascular pial collaterals may 
3. Observations (1) and (2) need to be supplemented by 
the following clinical experience: Even if the occlusion 
persists (e.g., when recanalization fails for technical 
reasons) there is a certain, yet low number of patients 
who can achieve favorable outcome (with complete pro-
tection of the penumbra). However, this applies only if 
strong filling of the macrovascular pial arterial tree is 
present (a representative example of this observation is 
given in the lower row of Fig. 1).
This third observation has always impressed, and also 
relieved, caring clinicians and neuropathologists alike, start-
ing with Charcot in 1882. He reported early that a major 
intracranial cerebral artery may be found occluded without 
the consequence of any structural cerebral injury down-
stream: “You must not think, gentlemen, that all obstruc-
tions of this kind would necessarily and inevitably produce 
Fig. 1 Strong association between collateral status at baseline and 
outcome. Upper row from left to right: Baseline frontal digital subtrac-
tion angiography (DSA) projection in arterial, parenchymal and early 
venous phase shows poor filling of the macrovascular pial arterial tree 
in right M1 occlusion. Despite successful recanalization (thrombolysis 
in cerebral infarction (TICI) 2b, not shown) unfavorable outcome with 
complete middle cerebral artery (MCA) infarction and hemorrhagic 
transformation ensued necessitating decompression hemicraniectomy 
(cranial computed tomography (CCT) on upper right). Middle row: 
Strong filling of pial collaterals at baseline in in right M1 occlusion. 
After successful recanalization (TICI 2b, not shown) favorable out-
come was observed with only limited striatal infarction conspicuous 
by mild contrast extravasation. Lower row: Strong filling of pial col-
laterals at baseline in right internal carotid artery (ICA) occlusion 
(contralateral/left ICA injected). Even though recanalization could not 
be achieved in this case, neither by transfemoral access nor by direct 
carotid puncture, outcome was still favorable with only limited striatal 
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Hemodynamic consequences after M1 occlusion
Immediately after the abrupt embolic occlusion of a cere-
bral artery, blood flow behind the site of occlusion does not 
drop to zero as one might intuitively assume. Rather, it is 
maintained at a reduced level by residual flow distally to the 
occlusion [16]. Residual arterial inflow into macrovascular 
sites located distally to the occlusion is provided through 
a macrovascular network of collateral channels at the pial 
surface and also at the base of the brain. The collaterals rel-
evant to the situation of an acute occlusion are represented 
by the pial macrovascular anastomoses with neighboring 
territories at the brain surface and/or by interconnected arte-
rial segments at the base of the brain belonging to the circle 
of Willis. In the case of an occlusion of the M1 segment of 
the MCA, which is one of the most frequent culprit loca-
tions leading to severe ischemic stroke, residual flow dis-
tal to M1 depends mainly on the pial collateral and not the 
basal anastomoses of the circle of Willis. In such a situation, 
collateral flow circumventing the occlusion cannot be pro-
vided directly by the circle of Willis because its orifices lie 
proximally to the site of occlusion (M1). Therefore, in the 
event of an M1 occlusion, collateral flow into the ischemic 
M1 field is provided through the pial anastomoses between 
the ischemic and its neighboring territories of the anterior 
and posterior cerebral arteries located on the convex brain 
surface. Consequently, in an M1 occlusion pial collateral 
flow is provided relatively independent of the frequently 
occurring anatomical variations in the circle of Willis. For 
example, if the ipsilateral A1 segment is aplastic/hypoplas-
tic, the contralateral A1 segment is typically dominant. It 
thus provides bilateral filling of both territories of the ante-
rior cerebral artery (ACA; in humans and primates via the 
anterior communicating artery), and in this way provides 
pial collateral flow into the ipsilateral ischemic field (MCA 
territory) [17]. By contrast, if the ipsilateral A1 segment is 
dominant or codominant, pial collateral flow to the ipsilat-
eral ischemic MCA territory comes via the ipsilateral A1 
segment [17]. In both situations, substantial contributions 
may also come through the posterior cerebral artery (PCA) 
and its macrovascular pial anastomoses with the MCA ter-
ritory mainly at its dorsal temporoparietal and temporooc-
cipital edges.
The term “macrovascular pial” in this text refers to sec-
ond-, third-, or fourth order branches of the major cerebral 
arteries on the brain surface and their macrovascular anas-
tomoses connecting their respective terminal segments. For 
the MCA, these branches are commonly referred to as M2–
M4 segments: M2 = the insular segments, M3 = the opercu-
lar segments and M4 = the terminal segments which overlie 
the convex brain surface [18]. A similarly useful and hierar-
chical nomenclature is established also for the anterior and 
posterior cerebral arteries. In a typical large-vessel occlu-
not be a dominant cause but only a secondary inevitable 
consequence of the progressive infarction of the penumbra. 
Accordingly, the collapse of blood flow in the pial collateral 
circulation may just be a macrovascular upstream (proxi-
mal) consequence of the pathological cellular and molecular 
events which occur further downstream (distally) within the 
ischemic microcirculation and which ultimately converge 
in microvascular failure. The two alternative possibilities 
of macrovascular failure preceding microvascular failure or 
vice versa may not mutually exclude each other completely. 
However, a separation seems necessary at least because 
future therapeutic targets need to be prioritized for experi-
mental research and its clinical evaluation. In other words, 
it is reasonable to attempt to differentiate whether it is more 
promising to tackle the structural and/or functional capac-
ity of pial collaterals upstream or, alternatively, to focus on 
the cellular and molecular mechanisms of ischemic micro-
vascular failure downstream, or consider both as equally 
important targets.
One of the most convincing arguments denying that the 
pial collateral macrovasculature plays a dominant causative 
role in the progression of ischemic infarction recognizes 
vascular resistance as a key parameter. Total cerebrovascu-
lar resistance usually refers to the entire brain or an entire 
hemisphere owing to the fact that clinical and experimen-
tal methods of investigation can grasp this measure only on 
a global level. However, for the purpose of understanding 
the resistance properties of a certain compartment (e.g., 
the macro- vs. the microvasculature) or of a certain vascu-
lar segment (e.g., the pial collaterals), the perfusion path 
which leads into the specific vascular field/territory of inter-
est needs to be deconstructed and considered in isolation 
[14]. Accordingly, the macrovascular bed is to be separated 
from the microvascular compartment if only the macrovas-
cular contribution to resistance shall be considered. Now, if 
the isolated resistance of the macrovascular bed, under the 
physiological condition of an open middle-cerebral-artery 
(MCA) was similar to the isolated resistance of the col-
lateral macrovascular perfusion path under the pathologi-
cal condition of an M1 occlusion, then the macrovascular 
blood flow into the ischemic field downstream of the culprit 
occlusion should not critically depend on the macrovascular 
collateral channels, which connect the ischemic field with 
its neighboring vascular territories [9, 15]. In other words, 
if there was no or hardly any difference in the isolated mac-
rovascular resistance between the normal/physiological and 
the collateral/pathological perfusion path, then the capacity 
of the collateral channels themselves should not be a limit-
ing factor for blood flow into the ischemic field, and hence 
the pial collaterals should not influence the spatiotemporal 
dynamics of progressive penumbral infarction substantially. 
This argument is worth being considered further and needs 
to be explained in more detail.
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via collateral pathways connecting the ischemic MCA field 
(behind the occlusion) with the neighboring territories of 
the anterior and posterior cerebral arteries.
These pial anastomoses are terminal macrovascular con-
nections between the distal M4 branches on one side and 
the terminal macrovascular branches of either the ACA or 
PCA on the other side (Fig. 2). The structure of these pial 
macrovascular collateral channels had been described for 
the human brain by Heubner [22], Duret [23], Testut [24], 
Beevor [25], and others, and was then reported in 1953 with 
particular detail by vander Eecken [19]. Vander Eecken 
and coworkers counted and measured these anastomo-
ses in human brains: Their average number between ACA 
↔ MCA was 5.4 ± 1.7 (average diameter of 319 ± 87 μm) 
and 3.8 ± 0.9 between PCA ↔ MCA (average diameter of 
362 ± 98 μm) [19]. Most of these channels are located in the 
depth of a sulcus and some overlie the gyral surface [19]. 
With modern fluoroscopy technology, including digital flat-
panel detector DSA, which typically enables a pixel-by-
pixel resolution of 100–200 microns [26], these anastomotic 
segments of the pial macrovasculature can be resolved. 
However, even with such exquisite structural resolution, the 
reliable visual recognition of the entirety of macrovascu-
lar collaterals remains difficult because of the complexity 
sion, for example, of the M1 segment, its M2–M4 segments 
lie immediately distal (M2) to the site of occlusion as well 
as further distal on the opercular parts (M3) and the convex 
surface (M4) of the brain.
Those vascular structures that eventually carry the flow-
ing arterial blood into the brain parenchyma are, however, 
not the macrovascular pial M2–M4 segments but a dense 
network of pial arterioles on the brain surface and the perfo-
rating arterioles, both of which mark the transition between 
the macro- and micro-circulation. The terminal macrovas-
cular MCA segments (M4) typically span a size range of 
250–1000 microns [19, 20], whereas the network of surface 
and penetrating arterioles typically ranges in diameter from 
40 to 280 microns, according to the work of Duvernoy [21]. 
The “penetrating” or “perforating” arterioles branch off 
from the pial surface network. At the cortical surface these 
arterioles “perforate” the cortex and reach into the subcor-
tex/white matter. At the base of the brain these perforators 
“perforate” the anterior perforate substance and reach into 
the base of the brain traversing (and supplying) white matter 
and deep grey matter (i.e., the basal ganglia). Immediately 
after an M1 occlusion, macrovascular blood flow can no 
longer reach the M2–M4 segments along the physiological 
path (via the open M1 segment) but has to arrive instead 
Fig. 2 Macrovascular pial anastomosis between neighboring terri-
tories visualized by digital subtraction angiography (one exemplary 
perirolandic anastomosis between anterior cerebral artery (ACA) and 
middle cerebral artery (MCA) territory). Upper left: Left-sided oc-
clusion of M1 segment (left internal carotid artery (ICA) Injection). 
The opacification in the arterial phase shows complete filling of ACA 
territory with far-reaching leptomeningeal terminal branches of the 
ACA arching over the brain convexity and backfilling terminal M4 
segments of the ischemic MCA field. Lower left (zoomed): The ter-
minal ACA segment fills in antegrade fashion (green dots and green 
arrow), whereas the terminal M4 segment (red dots and red arrow) 
is filled in retrograde direction (from medial to lateral). Upper right: 
After complete endovascular recanalization of this left M1 occlusion, 
opacification in the late arterial phase shows a complete filling of ACA 
and MCA territories each in antegrade fashion, leaving the typical, 
physiological borderzone of perfusion between these territories. Lower 
right (zoomed): The same terminal segments of the ACA (green dots, 
green arrow) and the MCA (red dots, red arrow now indicating rever-
sal of flow from lateral to medial) are shown as before recanalization 
(lower left). Now, after recanalization, the terminal M4 segment fills in 
the reverse, physiological direction (from lateral to medial), which is 
indicated by the reversed red arrow
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With the M1 segment occluded, the direction of flow in 
the pial collateral channels is reversed as compared to the 
physiological condition of an open M1 segment. In many 
other parts of the pial macrovascular M2–M4 arterial net-
work, macrovascular blood flow distal to the occlusion 
will also be in reverse direction. Interestingly, however, 
the direction of flow in the ischemic field is not necessar-
ily reversed everywhere (at all points of the macro- and 
microvascular network) contradicting what one would read-
ily believe. This can be explained by the superficial, intra-
cortical, and intra-subcortical three-dimensional structural 
complexity of the macro- and microvascular arterial net-
work [32–35]. Thus, flow reversal occurs in only approxi-
mately 50 % of the pial macrovascular and in only 12 % of 
the pial arterioral surface network within the ischemic field 
[36, 37]. This becomes understandable when we consider 
the main direction of flow input into the cortical/subcortical 
microcirculation, which is provided through the perforating 
arterioles. In these precapillary vessels the direction of flow 
will be robustly antegrade, that is, from superficial to deeper 
layers irrespective of the direction of flow in the superficial 
vascular network, from which these perforators originate 
and receive flow input.
After an M1 occlusion, at those points which lie most 
distal from their source of supply the direction of macrovas-
cular flow will be certainly reversed: Macrovascular blood 
flow in the M1 segment immediately behind the occlusion 
will be reversed and directed from lateral to medial (from 
M4/M3 into M2/M1). Conversely, under healthy condi-
tions and after recanalization, it will be (re-) directed in the 
opposite direction, that is, from the terminal carotid and 
proximal M1 segment located medially to the distal M1 
and M2–M4 segments located laterally (physiological/ante-
grade direction).
Macrovascular resistance of the collateral 
perfusion path
As mentioned earlier, under the condition of an M1 occlu-
sion, the macrovascular resistance of the collateral perfu-
sion path (comprising the collateral channels of ACA ↔ 
MCA and PCA ↔ MCA) constitutes an important argument 
for seriously questioning if macrovascular collateral chan-
nels can play a dominant role at all in the progressive infarc-
tion of the penumbra.
According to Hagen–Poiseuille’s law, the most influen-
tial factor by far (with fourth power) determining macrovas-
cular resistance is the total diameter of the macrovascular 
pial collateral path. On the basis of the most detailed mor-
phometric anatomical data available so far [19], this total 
diameter can be approximated to 3–4 mm (average num-
ber of pial ACA ↔ MCA and PCA ↔ MCA anastomoses 
of the brain surface which hides many of these anastomo-
ses behind multiple superimpositions. At least, the reliable 
visual detection of some of these anastomoses is possible 
(Fig. 2) and sometimes facilitated by sagittal projection. In a 
sagittal view, these macrovascular arterial segments span in 
a fan-like manner over the convex brain surface and appear 
as continuations of the terminal fourth order branches of the 
MCA connecting anteriorly (frontally), superiorly (fronto-
parietally), posteriorly and inferiorly (parietotemporally) 
with the terminal macrovascular branches of the ACA or 
PCA.
In healthy conditions, the anatomical–topographical 
position of these anastomoses is identical to the position of 
the physiological watershed zone of perfusion because this 
is where the distance to the neighboring source territories 
is greatest (e.g., the MCA field on the lateral side and ACA 
field on the medial side in antero–posterior view, Fig. 2). 
Obviously, the anatomical positions of these macrovascu-
lar anastomoses remain structurally fixed. The watershed 
zone of perfusion, however, is variable as a function of the 
balance in perfusion pressure between the neighboring ter-
ritories. Therefore, under the pathological condition of an 
M1 occlusion, this watershed zone of perfusion moves away 
from the position of the collateral anastomoses towards the 
insula (moving across the convex brain surface from medial 
to lateral-inferior and into the Sylvian fissure). The insula is 
located just distal to the occluded M1 vessel segment and 
thus, under the condition of an M1 occlusion, represents the 
cortical region where the distance to the nourishing territo-
ries (ACA and PCA) is maximized (with blood flow from 
ACA/PCA passing through their collateral anastomoses 
with the M4 segments into the ischemic MCA field).
For this reason, the highest intensity of the perfusion 
deficit can be observed exactly in this functional end zone 
of M1 occlusion [27, 28], where the cortical core of infarc-
tion appears earliest and where it can be detected radiologi-
cally by early signs of infarction, for example, by CT as 
edema/hypoattenuation of the insular cortical ribbon [29, 
30]. Cortical infarction typically progresses from the insular 
core over the opercular regions and into the convex brain 
surface areas of the frontoparietal, the superior, polar, and 
middle temporal cortex. This process occurs with variable 
spatial extension and with variable temporal dynamics 
which represents the variable recruitment of the penumbra 
(i.e., tissue-at-risk) by irreversible structural infarction. It 
is the aim of acute stroke therapy to protect or salvage the 
penumbra by fast recanalization and thereby to prevent that 
hypoxic-ischemic cell-death/infarction extends completely 
and spreads into the penumbra. Therapeutic recanalization 
typically does not aim at the early core of infarction since, 
in this region, ischemia is so profound that cell death has 
usually already occurred rather resembling instantaneous 
anoxic- than protracted hypoxic-ischemic cell death [31].
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blood plasma but not for the corpuscular fraction of blood. 
For the resistance properties of the macrocirculation under 
ischemic conditions, however, these two simplifications 
may be permissible and not represent oversimplifications 
for the following two reasons:
1. Functional alterations of the diameter of a vessel and/
or the tone of the vascular wall are mediated by mecha-
nisms of autoregulation. It can be assumed for severe 
ischemia that autoregulative mechanisms will likely 
be exhausted in the macro- and microcirculation with 
a consequence of maximum vasodilatation and loss 
of vascular tone [36]. Therefore, it seems unlikely for 
the regulation of vascular resistance that autoregula-
tive mechanisms should dominate the structural capac-
ity of the collateral circulation under the condition of 
ischemia.
2. With regard to the functional properties of blood it has 
to be stated that “with diminishing vessel diameter, the 
particulate nature of blood dominates the resistance to 
flow” [39]. Therefore, it can be expected that any altera-
tion of blood viscosity must have its most pronounced 
effect on the microvascular resistance rather than on the 
macrovascular resistance. For this reason, it seems also 
unlikely for the regulation of vascular resistance that the 
functional viscous properties of blood itself dominate 
over the structural capacity of the collateral circulation, 
at least as far as the macrovascular path is concerned.
Blood viscosity is increased at the low flow velocities pre-
vailing in the microcirculation and is decreased at the high 
flow velocities of the macrocirculation. Indeed, the viscos-
ity of blood of acute stroke patients is further increased as 
could be shown by ex vivo viscometry [40]. Interestingly, 
this increase depends on blood flow velocity and is most 
marked at the low blood velocities/at low shear rates such 
as occurring in the microcirculation and not the macro-
circulation [40]. Recently, it could be shown also in vivo 
that during low flow conditions such as during ischemia 
the apparent viscosity of blood increases [41]. This effect 
could be explained by the reduction of a so-called cell-free 
layer between streaming blood layers and the endothelium 
[41]. Under normal conditions of higher shear the corpus-
cular blood elements are forced away from the endothelium 
giving way for a cell-free layer which secures a decrease 
in apparent viscosity. At lower shear rates the thickness of 
the cell-free layer diminishes with the effect that apparent 
viscosity increases and with it microvascular resistance 
[41]. This modulation of viscosity represents a property not 
intrinsic to the structure or function of the microcirculation 
but to blood itself.
multiplied by their average diameter). Even in a subject 
with unfavorable variation of these channels with a total 
number and/or diameter in the lower range, the total diam-
eter sum would still amount to approximately 2.5–3 mm. 
This would correspond very closely to the usual total distal 
diameter of the physiological perfusion path, which is rep-
resented by the M1 segment itself [18, 38]. Because of these 
similarities in the diameter sum, it can be assumed that the 
total macrovascular resistance against physiological unob-
structed blood flow (i.e., along the usual path via an open 
M1 segment), should not be substantially different than for 
the pathological condition of obstructed flow (i.e., along the 
collateral path via the macrovascular pial anastomoses if the 
M1 segment is occluded).
Although certainly the dominant factor, total diameter 
obviously is not the only structural determinant of mac-
rovascular resistance in Hagen–Poiseuille’s equation. The 
second structural factor determining the vascular resistance 
of the perfusion path is its (tube) length. The difference 
in path length between the two conditions (M1 open vs. 
occluded) at first glance may seem substantial and relevant. 
When estimated from the carotid-T, which represents the 
bifurcation where blood will either flow in the physiologi-
cal direction (into the open M1 segment) or deflect into the 
pathological path (into the ipsilateral A1 segment if the M1 
segment is occluded), the length of the physiological mac-
rovascular path (from the carotid-T via M1 into M2 located 
at the center of the insula) in an adult human brain measures 
approximately 5 cm. By contrast, the length of the patho-
logical parallel collateral paths measures approximately 
20–25 cm: from the same starting point at the carotid-T into 
the A1 segment, moving around the genu of the corpus cal-
losum, obliquely ascending in the midline from anterior to 
posterior and then arching over the convexity from medial 
to lateral, for example, in the perirolandic region, and finally 
flowing down (via a pial anastomosis) into a terminal M4 
segment (and from there towards M3/M2). The length dif-
ference of around 15–20 cm between these two exemplary 
pathways (shorter unobstructed pathway via open M1 vs. 
longer collateral pathway under M1 occlusion) seems sub-
stantial, however, only in absolute terms. It seems negligible 
when contemplated in relative terms, that is, when the rela-
tion to the total length of the macrovascular resistance path, 
which must include also the much longer distance to the 
heart, is taken into account.
When Hagen–Poiseuille’s physical law is directly 
applied to the human physiology of blood rheology and 
hemodynamics, the functional properties of the vasculature 
and blood as a non-Newtonian fluid are neglected by mak-
ing two simplifications: (1) Vessels are treated as rigid tubes 
with a constant diameter and tone, and (2) the viscosity of 
blood is assumed to be constant, which is largely true for 
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By the same group another important observation was 
made which was already referred to above: The viscosity 
of patient blood obtained early after acute ischemic stroke 
is particularly increased at low shear rates, which clearly 
points to the fact that resistance mainly comes into effect at 
the level of the microcirculation [44]. These authors were 
among the first to hypothesize that “changes in the blood 
itself”, possibly through aggregation of its corpuscular/cel-
lular elements, were responsible for the increase of viscosity 
at low shear rates occurring predominantly in the micro- 
and not the macro-circulation [44]. In subsequent decades 
it could be clearly shown that blood cell-to-cell and blood 
cell-to-endothelium as well as blood-cell-to-subendothe-
lium interactions (reviewed in detail, e.g., by del Zoppo in 
2003 [45] and by De Meyer in 2016 [46]) lead to microvas-
cular failure and may result in a complete obstruction of the 
microcirculation thereby excessively raising the microvas-
cular resistance. It is now firmly established that endothelial 
adhesion of white blood cells [47–49], endothelial adhe-
sion of platelets [50–52], and ultimately thrombus forma-
tion involving also the intrinsic coagulation system [53] are 
mechanisms, which are critical for the progressive infarc-
tion of the penumbra and which all operate on the level 
of the ischemic microcirculation. Moreover, a complex 
molecular and cellular interaction between thrombotic and 
inflammatory pathways has been implied recently suggest-
ing that the ischemic degeneration of the microvasculature 
and of the adjacent neuronal and glial brain substance may 
be a joint result of microvascular thrombosis and inflam-
matory mechanisms jointly called "thromboinflammation" 
[46, 54–56]. The structural/functional final result of these 
events is the complete luminal occlusion of the ischemic 
microcirculation.
In consistence with these mechanisms, a myriad of cel-
lular and molecular targets have been identified, which can 
already be used effectively to alleviate, decelerate, or desta-
bilize microvascular obstruction [57]. As a consequence, it 
has become possible to achieve a significant prolongation 
of the time window for efficient recanalization and inhibit 
infarct expansion within the penumbra, however, only under 
experimental conditions. In contrast to the high number of 
experimentally effective targets, so far, not a single of these 
strategies could be made available for human use because 
clinical efficacy could be demonstrated in none of the clini-
cal studies including phase II and III trials [31, 57]. As a 
result of this discrepancy between bench and bedside, it has 
always been called into question if the most widely used 
rodent model, the transient occlusion of the MCA, could 
ever reflect human stroke appropriately [31]. Another expla-
nation seems possible as well but has found clearly less 
consideration: In human stroke the therapeutic effective-
ness of macrovascular recanalization did just not reflect the 
experimental situation well enough. In a typical experimen-
Collapse of collateral flow secondary to 
microvascular failure?
For all these reasons, it seems unlikely that any structural 
or functional limitation of the collateral macro-circulation 
should play a dominant role in the progression of ischemic 
infarction. Instead, it appears more plausible that structural 
and/or functional properties of the micro-circulation cru-
cially determine total vascular resistance during ischemia 
and, as a consequence thereof also govern cerebral blood 
flow through the upstream collateral macrovascular path-
ways. Obviously, apart from vascular resistance, the pres-
sure drop across the total vascular bed is the other force 
which drives (collateral) flow. Indeed, the close guidance 
of systemic arterial pressure to maintain cerebral perfusion 
pressure under ischemia is an obvious and already well-
exhausted therapeutic strategy before and during recanaliza-
tion therapy. However, no therapeutic strategy exists to date 
which aims at the cellular and molecular mechanisms con-
verging in microvascular failure. This failure is ultimately 
associated with an excessive increase of microvascular 
resistance and finally complete microvascular obstruction.
As in other organs, also the total vascular resistance of 
the brain (cerebrovascular resistance, CVR) under healthy 
conditions but even more so during ischemia is heavily 
dominated by the microcirculation. It could be estimated 
that the largest part of the total or regional CVR (the term 
“regional” referring to a certain vascular field) under healthy 
conditions is determined by the pial arterioles [36]. Another 
early experimental finding strongly underlines that the CVR 
is mainly governed by the resistance of the microcirculation 
to a much larger degree than by any contribution of macro-
vascular segments upstream. Through costly and invasive 
experimental work, Bakay and Sweet already showed in 
1952 that only 20 % of the mean systemic arterial pressure is 
needed to drive blood through the macrovascular segments 
of the systemic and cerebral arterial circulation [42]. It fol-
lows that the biggest share of the perfusion pressure (drop) 
needs to be spent to overcome the downstream resistance of 
the microcirculation.
Overwhelming experimental evidence on the cellular 
and molecular level indicates why microvascular resistance 
increases excessively during ischemia. Starting with the 
early work of Ames et al. it became obvious that swelling of 
the microvascular endothelium in the ischemic brain and of 
the perimicrovascular glia causes a significant narrowing of 
the microvascular lumen. If ischemia is severe and endures 
long enough even complete microvascular obstruction 
ensues—this was coined the “no-reflow” phenomenon [43]. 
This denomination implies that under certain unfavorable 
circumstances effective reperfusion of the microcirculation 
may not occur even if proximal/macrovascular recanaliza-
tion is successfully achieved [43].
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recanalization. How can it be explained that the patency and 
antegrade filling in segments located distally to the occluded 
vessel segment after its recanalization should depend on the 
degree and robustness of their retrograde collateral filling 
before recanalization? Distal embolization has been offered 
as one explanation; however, it would remain difficult to 
explain why, particularly at the moment of antegrade flow 
reversal/restoration, distal embolization should occur more 
frequently in patients with poor retrograde collateral filling 
(before recanalization). Enhanced transportation of intrave-
nously administered thrombolytics to the ischemic field via 
the collateral pathways preventing secondary occlusions in 
the downstream pial arterial tree was also offered and can-
not be refuted [6]. Yet another explanation seems plausible 
which also takes into account the probable hemodynamic 
and rheologic effects that the distal ischemic microcircu-
lation has on the proximal pial macrovasculature. Despite 
successful local recanalization of the proximal culprit occlu-
sion, distal filling defects or stasis filling responsible for 
TICI 2a or worse could merely be an effect of an increased 
regional microvascular resistance during progressive infarc-
tion. This explanation is supported at least by evidence 
from the macro- and microvasculature of the heart during 
ischemia/reperfusion.
Similar to the angiographic appearance of unfavorable 
TICI scores (stasis filling and/or filling defects in the pial 
macrovasculature distal to the culprit occlusion), worse 
TIMI flow grades in the heart have been clearly linked to 
alterations in microvascular resistance [61, 62]. In the epi-
cardial circulation, this link between macro- and microvas-
culature has not only been established by reasoning but also 
by functional hemodynamic invasive measurements (i.e., 
empirical indices of microvascular resistance) [63–65], 
which are not available for the pial macrovasculature in 
humans.
It can be summarized that after the advance of highly 
effective recanalization strategies, the ultimate goal in 
stroke treatment now becomes to gain more time for the 
large number of patients in whom recanalization cannot be 
provided fast enough. To sustain and prolong the viability of 
the ischemic tissue downstream of the culprit macrovascu-
lar occlusion (i.e., of the penumbra) would “buy” more time 
for therapeutic recanalization by endovascular mechanical, 
intravenous thrombolytic, or both means. Interindividual 
differences in the spatial extension and in the temporal 
dynamics of progressive penumbral infarction, and thus, 
in the potential to achieve a favorable clinical response to 
therapeutic recanalization could be clearly associated with 
salient interindividual characteristics of collateral macro-
vascular blood flow reaching the ischemic field through pial 
collateral channels/anastomoses (before recanalization). 
Such a strong association suggests but cannot prove cau-
tal setting, the occlusive stimulus is simply removed after a 
defined time interval to study how the progressive infarction 
of the penumbra can be delayed. Such a complete control of 
macrovascular recanalization is not achievable in the human 
setting. For example, the recanalization rates of only intra-
venous (IV) thrombolysis are low. The best available data 
in this regard came from early phase II thrombolysis trials 
documenting by gold-standard invasive angiography poor 
recanalization rates of only 8 % for ICA, 26 % for M1, and 
35 % for M2 occlusions [58]. By comparison, in the wide-
spread thread occlusion models of embolic stroke in rodents, 
for obvious reasons, a near-perfect control of the recanaliza-
tion rate will be achievable certainly being close to 100 % 
(modelling ICA/M1 occlusion). Beyond the insufficient 
human recanalization rates of the past, other substantial dif-
ferences exist between the clinical and experimental condi-
tion. In human stroke, subocclusive thrombembolic partial 
occlusion is not a rare event, and it is typically not simulated 
by experimental research. Furthermore, thrombus fragmen-
tation with distal embolization either occurring spontane-
ously or during therapeutic intervention by mechanical 
thrombectomy and/or by pharmacological thrombolysis is 
not accounted for in the experimental situation.
To prolong the viability of and finally salvage the pen-
umbra, or at least clinically significant parts of it, with 
strategies focusing on the ischemic microcirculation, may 
require timely and complete macrovascular recanalization 
as a sine qua non condition that has to be established in con-
junction. For large-vessel macrovascular occlusions, which 
are typically modelled by experimental embolic stroke, 
only recently, the therapeutic recanalization rates in humans 
could be increased substantially by endovascular throm-
bectomy, approaching or even exceeding a rate of 80% of 
complete recanalization followed by strongly positive clini-
cal effects [1-5]. with strong clinical effects [1–5]. Such an 
improvement of recanalization rates in humans may only 
now facilitate the breakthrough of adjunctive strategies that 
prevent or reverse the molecular and cellular events which 
lead to downstream microvascular failure and an increase 
of resistance.
The angiographic data from several endovascular stroke 
trials has enabled another noteworthy observation also cen-
tering on the role of the macrovascular pial collateral cir-
culation in acute ischemic stroke [59, 60]. Poor collateral 
flow at baseline (before recanalization) is strongly predic-
tive of poor recanalization/reperfusion itself [59, 60]: It 
was observed that lower recanalization/reperfusion grades 
as scored by the modified thrombolysis in cerebral infarc-
tion (TICI) scale were closely associated with poorer col-
laterals before recanalization and that, by contrast, higher/
better grades of TICI (in particular 2b and 3) were much 
more likely to occur in the case of strong collaterals before 
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sality (between interindividual differences in the structural 
and/or functional properties of the macrovascular collateral 
channels and the notorious clinical differences in response 
after recanalization). There exist other reasons to believe 
that poor collateral backfilling before recanalization is not 
the cause of unfavorably fast progressive infarction or 
lack of response to recanalization. Poor collateral backfill-
ing of the pial macrovasculature may just be a secondary 
consequence of increasing peripheral/distal (micro-)vascu-
lar resistance which may be inevitably caused during pro-
gressive infarction by molecular and cellular mechanisms 
well-known by experimental investigation to compromise 
microvascular function during ischemia/reperfusion during 
ischemia/reperfusion. In addition, human data on the ana-
tomical structure of the macrovascular collateral anastomo-
ses and on the altered viscous properties of blood during 
ischemic stroke suggest that crucial interindividual differ-
ences might exist with regard to the resistance properties 
of the micro- rather than the pial macrocirculation. In the 
future, the question whether it is macro- or microvascular 
failure or both that drives the progressive infarction of the 
penumbra will be crucial. To be able to address this question 
will depend on the development of methods that enable the 
measurement of cerebrovascular resistance during ischemia 
and after recanalization. However, we can see particularly 
in the past work from Hossmann and coworkers, that a care-
ful and very elaborate experimental design has to be under-
taken to be able to differentiate the contributions of different 
compartments or vascular segments to the total resistance 
of a certain vascular region [14]. These experimental meth-
ods obviously are not readily applicable in the clinical situ-
ation. Therefore, the further development of radiological 
imaging methods such as CT- or MR-perfusion needs to be 
challenged to finally answer if, also in human stroke, micro-
vascular failure and increased resistance play an equally 
substantial role as in the experimental setting. In fact, these 
noninvasive imaging techniques already deliver perfusion 
information on a tissue-/microvascular level but it is still not 
possible to differentiate between the micro- and macrovas-
cular contribution to the respective perfusion contrast.
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